Breakthroughs in identifying tumor biomarkers in liver, gastric, prostate, lung and other cancers and are accelerating radionuclide therapies. For patients with hard-to-treat cancers, the hurdle often lies in the location. For a pancreatic tumor situated close to vital organs, or a cancer embedded deep within the brain, drug developers have always faced a critical dilemma – even if a drug i... [6980 chars]
2026 Copyright © News-Matic.com. All Rights Reserved
